Yield - Short Interest 15.67% Market Cap $164.78M Volume 456,961 Prev. Close $3.58 CRGX Analysis Cargo Therapeutics: High Venture Interest But Still Early Days For This CAR-T PlayerAvisol Capital PartnersSun, Jan. 28, 20242 Comments IPO Update: Cargo Therapeutics Readies Plans For $300 Mill...
Latest On CARGO Therapeutics Inc ALL CNBCINVESTING CLUBPROSummaryNewsProfileEarningsPeersFinancialsOptionsOwnership KEY STATS Open0.00 Day High0.00 Day Low0.00 Prev Close4.12 52 Week High25.45 52 Week High Date09/18/24 52 Week Low3.00 52 Week Low Date01/30/25 Market Cap189.974M Shares Out46.11M...
Market Cap 0.20B Stock Price 4.02 About CARGO Therapeutics CARGO Therapeutics (CRGX) operates as a biotechnology company that focuses on developing Chimeric Antigen Receptor (CAR) T-cell therapies for cancer treatment. The company's main offerings include engineering CAR T-cell therapies designed to...
Get the latest insights on CARGO Therapeutics, Inc. Common Stock (CRGX) with press releases and corporate news to help you in your trading and investing decisions.
Get real-time updates on CARGO Therapeutics, Inc. Common Stock (CRGX) stock quotes, trades, and more. Make informed investments with Nasdaq.
CRGX | Complete CARGO Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.